SAMUEL BRANDON MILLER
Pilots at Dayton Ave, Seattle, WA
License number
Washington A5121620
Issued Date
Jan 2017
Expiration Date
Jan 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
11237 Dayton Ave N, Seattle, WA 98133
Professional information
Samuel Miller, Seattle WA
Work:
University Of Washington Medical Ctr
1959 Ne Pacific St, Seattle, WA 98195
1959 Ne Pacific St, Seattle, WA 98195
Dr. Samuel I Miller, Seattle WA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
1959 NE Pacific St STE 357710, Seattle 98195
(206) 598-7600 (Phone), (206) 598-2105 (Fax)
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
(206) 598-5637 (Phone), (206) 598-4303 (Fax)
(206) 598-7600 (Phone), (206) 598-2105 (Fax)
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
(206) 598-5637 (Phone), (206) 598-4303 (Fax)
Certifications:
Infectious Disease, 1988, Internal Medicine, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1959 NE Pacific St STE 357710, Seattle 98195
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
Harborview Medical Center
325 9Th Ave, Seattle 98104
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
Harborview Medical Center
325 9Th Ave, Seattle 98104
Education:
Medical School
Baylor University
Graduated: 1979
Massachusetts General Hospital
Baylor University
Graduated: 1979
Massachusetts General Hospital
Samuel I Miller, Seattle WA
Specialties:
Internist
Address:
University Of Washington Medical Ctr, Seattle, WA 98195
5-Substituted-2-Imino-Thiazolidinone Compounds And Their Use As Inhibitors Of Bacterial Infection
US Patent:
8252940, Aug 28, 2012
Filed:
Aug 16, 2010
Appl. No.:
12/856986
Inventors:
Heather B. Felise - Lynnwood WA, US
Samuel I. Miller - Seattle WA, US
Toni Kline - Seattle WA, US
Samuel I. Miller - Seattle WA, US
Toni Kline - Seattle WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
C07D 417/06, C07D 277/04, A61K 31/445, A61K 31/427
US Classification:
548184, 546209, 5462697, 514326, 514369
Abstract:
A method for inhibiting Gram-negative bacterial pathogenesis, a method of screening for compounds that inhibit type III secretion in Gram-negative bacteria, and compounds that inhibit type III secretion in Gram-negative bacteria.
Salmonella Secreted Proteins And Uses Thereof
US Patent:
6861247, Mar 1, 2005
Filed:
Nov 14, 1996
Appl. No.:
09/068804
Inventors:
Samuel I. Miller - Seattle WA, US
Assignee:
The General Hospital Corporation - Boston MA
International Classification:
C12N001/20, C12Q001/68, C12Q001/18, C07H021/04, A61K039/112
US Classification:
4352528, 435 4, 435 6, 435 30, 435 32, 435 38, 4352521, 435243, 536 221, 536 231, 536 237, 4242341, 4242581
Abstract:
Substantially pure Salmonella secreted proteins (Ssp), the sercetion of which is dependent upon the expession of PrgH; methods of diagnosing Salmonella infection; and live attenuated vaccine strains in which Ssp secretion is decreased.
Salmonella Vaccines
US Patent:
5843426, Dec 1, 1998
Filed:
Dec 1, 1995
Appl. No.:
8/565861
Inventors:
Samuel I. Miller - Seattle WA
John J. Mekalanos - Cambridge MA
John J. Mekalanos - Cambridge MA
Assignee:
The General Hospital Corporation - Boston MS
President and Fellows of Harvard College - Cambridge MS
President and Fellows of Harvard College - Cambridge MS
International Classification:
A61K 39112, C12N 1503, C12N 121
US Classification:
424 932
Abstract:
The invention features a Salmonella cell the virulence of which is attenuated by a deletion of a portion of the PhoQ gene and Salmonella cells having a deletion of the PhoQ gene and a deletion of the PhoP gene. The invention also features vaccines comprising such bacteria.